超越脱色:5227例中国白癜风患者的横断面研究
本研究对5227例常规治疗不满意的中国白癜风患者进行横断面分析,系统描述其临床与心理社会特征。结果显示非节段型占88.7%,73.2%处于进展期,21.2%合并症(主要为甲状腺疾病10.9%),94.2%有可见部位皮损。严重白癜风与男性、病程>10年及非节段型相关,生活质量受损与女性、严重白癜风、抑郁、低自尊及绝望感相关。
要点
- 中国白癜风患者以非节段型为主,多数处于进展期且累及可见部位。
- 严重白癜风与男性、病程>10年及非节段型独立相关。
- 生活质量受损与女性、严重白癜风、抑郁、低自尊及绝望感相关。
核心结论
- 中国白癜风患者面临慢性病程、可见部位脱色、合并症及心理困扰的多维负担,需整合皮肤科、心理及系统性干预的综合管理模式。
研究设计与样本
- 对5227例常规治疗不满意的中国白癜风患者进行横断面分析。
主要发现
- 非节段型占88.7%,进展期占73.2%,家族史占13.5%,合并症占21.2%(主要为甲状腺疾病10.9%)。
- 62%的患者在30岁前发病,79%曾接受≥2种治疗,94.2%有可见部位(面/颈/手)皮损,约80%表现为完全脱色。
- 严重白癜风与男性(aOR=2.17)、病程>10年(aOR=20.56)及非节段型(aOR=12.31)显著相关。
- 生活质量受损与女性(aOR=1.87)、严重白癜风(aOR=1.66)、抑郁(aOR=1.81)、低自尊(aOR=2.83)及绝望感(aOR=2.59)相关。
临床怎么用
- 应超越单纯脱色治疗,关注可见部位皮损、合并症筛查及心理社会干预。
- 对男性、病程>10年及非节段型患者需警惕严重白癜风。
- 对女性、严重白癜风、抑郁、低自尊及绝望感患者应评估生活质量并给予心理支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vitiligo is a chronic, disfiguring disease associated with autoimmune comorbidities and psychosocial burdens, although comprehensive Chinese population data remain limited. This study systematically characterizes the clinical and psychosocial profiles of treatment-seeking patients with vitiligo, addressing gaps in understanding disease severity, comorbidities, and mental health impacts to guide integrated management approaches. A cross-sectional analysis of 5227 Chinese patients with vitiligo after unsatisfactory conventional therapy was conducted. Among the 5227 patients with vitiligo, nonsegmental vitiligo (88.7%) predominated, with 73.2% in progressive stage. Family history was reported in 13.5%, and comorbidities (primarily thyroid disorders, 10.9%) occurred in 21.2%. Most patients (62%) developed vitiligo before the age of 30 years. All received prior treatments (79% received ≥2 therapies), and 94.2% had visible-area lesions (face/neck/hands), with ∼80% showing complete depigmentation. Severe vitiligo was significantly associated with male sex (adjusted OR [aOR] = 2.17), disease duration >10 years (aOR = 20.56), and nonsegmental subtype (aOR = 12.31). QOL impairment was observed in the following characteristics: female sex (aOR = 1.87), severe vitiligo (aOR = 1.66), depression (aOR = 1.81), low self-esteem (aOR = 2.83), and hopelessness (aOR = 2.59). Chinese patients with vitiligo face multidimensional burdens-chronicity, visible-area depigmentation, comorbidities, and psychological distress-exacerbated by fragmented treatments. Findings underscore the need for integrated management models combining dermatological, psychological, and systemic interventions beyond depigmentation-focused therapies.
引用
- Zhang R, Chen X, Huang H, et al. Beyond depigmentation: A cross-sectional study of 5227 Chinese patients with vitiligo. J Invest Dermatol. 2025. PMID: 41224191. doi:10.1016/j.jid.2025.10.603
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。